Rewritable Glycochips von Harris, L. G, Schofield, W. C. E, Doores, K. J, Davis, B. G, Badyal, J. P. S

Volltext

P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS‐COV‐2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS von Harrington, P., Saunders, J., Saha, C., Sheikh, A., Dillon, R., Raj, K., Cadman‐Davies, L., Lechmere, T., Khan, H., Woodley, C., Asirvatham, S., Curto‐Garcia, N., O'Sullivan, J., Kordasti, S., Radia, D., McLornan, D., Malim, M., Doores, K., Harrison, C., Lavallade, H.

Volltext

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies von Fielding, Ceri Alan, Sabberwal, Pragati, Williamson, James C, Greenwood, Edward J D, Crozier, Thomas W M, Zelek, Wioleta, Seow, Jeffrey, Graham, Carl, Huettner, Isabella, Edgeworth, Jonathan D, Price, David A, Morgan, Paul B, Ladell, Kristin, Eberl, Matthias, Humphreys, Ian R, Merrick, Blair, Doores, Katie, Wilson, Sam J, Lehner, Paul J, Wang, Eddie C Y, Stanton, Richard J

Volltext

P04-05. Requirements for antibody domain exchange explored through mutation of the germline 2G12 antibody von Huber, M, Le, K M, Doores, K J, Burton, DR

Volltext

P19-03. Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12 von Fulton, Z, Doores, K J, Scanlan, C N, Wormald, M R, Dwek, R A, Wilson, IA, Davis, B G

Volltext

P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope von Dunlop, DC, Mansab, F, Doores, K, Zitzmann, N, Smith, D, Burton, D, Dwek, R, Scanlan, C

Volltext

Engineered mice and B cell lines expressing broadly neutralizing antibodies and their unmutated precursors: tools for HIV vaccinology von Nemazee, D, Doyle-Cooper, C, Ota, T, Cooper, AB, Huber, M, Falkowska, E, Doores, K, Hangartner, L, Le, K, Sok, D, Jardine, J, Lifson, J, Wu, X, Mascola, JR, Poignard, P, Binley, JM, Chakrabarti, BK, Schief, WR, Wyatt, RT, Burton, DR

Volltext

055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study von Mahil, S.K., Bechman, K., Raharja, A., Domingo-Vila, C., Brown, M., Cope, A., Malim, M., Pollock, E., Seow, J., Barker, J., Norton, S., Galloway, J., Doores, K., Tree, T., Smith, C.

Volltext

P12-06. A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity von Doores, KJ, Fulton, Z, Scanlan, CN, Wormald, MR, Dwek, RA, Wilson, IA, Burton, DR, Davis, BG

Volltext

Cross-reactivity between HIV-1 bnAbs and parasite glycans von Poignard, P, Reichardt, N, Doores, K, Krumm, S, Landais, E, Brzezicka, K, Hokke, R, Angulo, J, Allan, F, Huettner, I, Emery, A, Serna, S, van Diepen, A

Volltext

Resistance of transmitted founder HIV-1 to IFITM-Mediated restriction von Foster, TL, Wilson, H, Iyer, SS, Coss, K, Doores, K, Smith, S, Kellam, P, Finzi, A, Borrow, P, Hahn, BH, Neil, SJD

Volltext

Exploring and Exploiting the Therapeutic Potential of Glycoconjugates von Doores, Katie J., Gamblin, David. P., Davis, Benjamin G.

Volltext

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies von Julien, J, Kong, L, Pejchal, R, Khayat, R, Lee, J, Stanfield, RS, Walker, LM, Doores, KJ, Folkowska, E, Poignard, P, Depetris, R, Sanders, RW, Koff, WC, Moore, JP, Ward, AB, Burton, DR, Wilson, IA

Volltext

Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort von Granger, LA, Huettner, I, Debeljak, F, Kaleebu, P, Schechter, M, Tambussi, G, Weber, J, Miro, JM, Phillips, R, Babiker, A, Cooper, DA, Fisher, M, Ramjee, G, Fidler, S, Frater, J, Fox, J, Doores, KJ

Volltext

A Diverse Antibody Response to the Gp120 N332 Glycan Epitope in an HIV-Infected Donor von Doores, K J, Le, K, Sok, D, Laserson, U, Vigneault, F, Laserson, J, Koller, D, Church, G, Poignard, P, Burton, D

Volltext

SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care von Gutmann, C, Takov, K, Burnap, SA, Singh, B, Ali, H, Theofilatos, K, Reed, E, Hasman, M, Nabeebaccus, A, Fish, M, McPhail, MJ, O'Gallagher, K, Schmidt, LE, Cassel, C, Rienks, M, Yin, X, Auzinger, G, Napoli, S, Mujib, SF, Trovato, F, Sanderson, B, Merrick, B, Niazi, U, Saqi, M, Dimitrakopoulou, K, Fernandez-Leiro, R, Braun, S, Kronstein-Wiedemann, R, Doores, KJ, Edgeworth, JD, Shah, AM, Bornstein, SR, Tonn, T, Hayday, AC, Giacca, M, Shankar-Hari, M, Mayr, M

Volltext

Direct deprotected glycosyl-asparagine ligation von Doores, Katie J, Mimura, Yusuke, Dwek, Raymond A, Rudd, Pauline M, Elliott, Tim, Davis, Benjamin G

Volltext

Ligand amplification in a dynamic combinatorial glycopeptide library von Hotchkiss, Tom, Kramer, Holger B, Doores, Katie J, Gamblin, David P, Oldham, Neil J, Davis, Benjamin G

Volltext

SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity von Rosa, A, Pye, VE, Graham, C, Muir, L, Seow, J, Ng, KW, Cook, NJ, Rees-Spear, C, Parker, E, Dos Santos, MS, Rosadas, C, Susana, A, Rhys, H, Nans, A, Masino, L, Roustan, C, Christodoulou, E, Ulferts, R, Wrobel, AG, Short, C-E, Fertleman, M, Sanders, RW, Heaney, J, Spyer, M, Kjaer, S, Riddell, A, Malim, MH, Beale, R, MacRae, J, Taylor, GP, Nastouli, E, Van Gils, MJ, Rosenthal, PB, Pizzato, M, McClure, MO, Tedder, RS, Kassiotis, G, McCoy, LE, Doores, KJ, Cherepanov, P

Volltext

"Polar patch" proteases as glycopeptiligases von Doores, Katie J, Davis, Benjamin G

Volltext